View Clinical Trial (Medical Research Study)
Mindfulness Based Stress Reduction for High Blood Pressure - NCT00440596-44304(Clinical Trial 164193)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Akron |
|
State:
|
|
OH |
| Zip Code: |
|
44304 |
| Conditions: |
|
Hypertension |
| Purpose: |
|
Nearly 60 million adults in the United States have high blood pressure (BP) in the
pre-hypertension (SBP 120-139 or DBP 80-89). Hypertension is estimated to account for 1 in 8
deaths in the world, and in the US the direct and indirect costs of high BP are estimated to
reach $59.7 billion in 2005. JNC-7 guidelines recommend lifestyle modifications for
prehypertension, followed by antihypertensive medication if BP progresses to Stage I
hypertension. Mindfulness-based Stress Reduction (MBSR) is an increasingly popular practice
that has been purported to alleviate stress and treat certain health conditions. Some stress
management therapies and one meditation therapy (e.g., Transcendental Meditation) have shown
promise in reducing elevated BP, but MBSR has not been evaluated as a treatment for high BP.
When added to lifestyle modification advice, MBSR may be an appropriate complementary
treatment for prehypertension. However, prior to a large randomized clinical trial of MBSR
for prehypertension and/or hypertension, pilot data is necessary to provide preliminary
evidence of a treatment effect and to evaluate feasibility. This feasibility randomized
clinical trial of MBSR for unmedicated prehypertension will provide preliminary evidence to
support a larger randomized clinical trial by evaluating the feasibility and safety of MBSR
as a complementary treatment for high BP and by documenting any treatment effect. Sixty
patients with unmedicated BP in the range of SBP 120-139 mm Hg or DBP 80-89 mm Hg will be
randomly assigned to MBSR or a progressive muscle relaxation control condition. All patients
will receive lifestyle modification advice. Patients will complete 8 weeks of MBSR delivered
in a group format by an experienced psychologist trained in MBSR or 8 weeks of progressive
muscle relaxation training matched for therapist contact and homework. Patients BP will be
assessed prior to randomization and following treatment by researchers blind to treatment
assignment. Accrual rates, acceptance of randomization, treatment adherence, treatment
fidelity, and patient satisfaction with treatment will be evaluated.
|
| Study summary: |
|
See brief summary |
| Criteria: |
|
Inclusion Criteria:
- prehypertension
- 30-60 years of age
Exclusion Criteria:
- normal BP
- hypertension
- pregnancy
- smoking
- use of antihypertensive medication |
|
|
|
| Study is available at: |
|
Summa Health System Akron, OH 44304 United States
Primary Contact: Richard Josephson, MD Email: josephsonr@akcardio.com Phone: 330-253-8195
Secondary Contact: Joel W Hughes, Ph.D Email: jhughes1@kent.edu Phone: 330-672-7721 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|